Home/Filings/4/0000899243-20-011292
4//SEC Filing

Nestle Health Science US Holdings, Inc. 4

Accession 0000899243-20-011292

CIK 0001631650other

Filed

Apr 23, 8:00 PM ET

Accepted

Apr 24, 4:45 PM ET

Size

11.2 KB

Accession

0000899243-20-011292

Insider Transaction Report

Form 4
Period: 2018-02-26
Transactions
  • Purchase

    Common Stock

    2018-11-28$30.27/sh+3,237,529$98,000,00311,727,113 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2018-02-26$32.00/sh+937,500$30,000,0008,489,584 total(indirect: See Footnote)
NESTLE SA
10% Owner
Transactions
  • Purchase

    Common Stock

    2018-02-26$32.00/sh+937,500$30,000,0008,489,584 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2018-11-28$30.27/sh+3,237,529$98,000,00311,727,113 total(indirect: See Footnote)
Transactions
  • Purchase

    Common Stock

    2018-02-26$32.00/sh+937,500$30,000,0008,489,584 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2018-11-28$30.27/sh+3,237,529$98,000,00311,727,113 total(indirect: See Footnote)
Footnotes (2)
  • [F1]Consists of 8,489,584 shares of Common Stock held by Nestle Health Science US Holdings, Inc. ("NHS"). NHS is a wholly owned subsidiary of NIMCO US, Inc. ("NIMCO"). The ultimate parent company of NHS and NIMCO is Nestle S.A. ("Nestle"). Each of these entities may be deemed to share voting and investment power with respect to all shares of Common Stock held by NHS. Each of NIMCO and Nestle disclaims beneficial ownership of such shares of Common Stock except to the extent of its pecuniary interest therein.
  • [F2]Consists of 11,727,113 shares of Common Stock held by Nestle Health Science US Holdings, Inc. ("NHS"). NHS is a wholly owned subsidiary of NIMCO US, Inc. ("NIMCO"). The ultimate parent company of NHS and NIMCO is Nestle S.A. ("Nestle"). Each of these entities may be deemed to share voting and investment power with respect to all shares of Common Stock held by NHS. Each of NIMCO and Nestle disclaims beneficial ownership of such shares of Common Stock except to the extent of its pecuniary interest therein.

Issuer

Aimmune Therapeutics, Inc.

CIK 0001631650

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001644164

Filing Metadata

Form type
4
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 4:45 PM ET
Size
11.2 KB